Skip to main content
Erschienen in: Supportive Care in Cancer 3/2015

01.03.2015 | Review Article

The perceived cancer-related financial hardship among patients and their families: a systematic review

verfasst von: Meram Azzani, April Camilla Roslani, Tin Tin Su

Erschienen in: Supportive Care in Cancer | Ausgabe 3/2015

Einloggen, um Zugang zu erhalten

Abstract

Purpose

The escalating health-care spending for cancer management has caused cancer patients to struggle further as a result of financial burden. This systematic review was carried out to investigate the prevalence of perceived financial hardship and associated factors among cancer patients and their families.

Methods

A systematic search for studies concerning the perception of financial burden among cancer patients and their families was conducted. Several electronic resources such as Medline, Elsevier (Science Direct), Web of Science, Embase, PubMed, CINAHL and Scopus (SciVerse) were searched. Additionally, manual search through indices citation was also thoroughly utilized. The main outcome of interest was the prevalence of perceived financial hardship among cancer patients and their families. Studies reported only the cost of cancer treatment and qualitative studies were excluded. Our search was limited to articles that were published from 2003 to 2013.

Result

Ten studies were included in this review and with a majority originating from high-income countries. The prevalence of the financial burden perception was reported between 14.8 and 78.8 %. The most frequent and significant risk factor reported associated with the perception of financial difficulty was the households with low income. Discontinuation of treatment and poverty were conversely the important consequences of financial burden in cancer patients and their families.

Conclusion

Evidently, cancer is a long-term illness that requires a high financial cost, and a significant number of cancer patients and families struggle with financial difficulty. Identifying such groups with a high risk of facing financial difficulty is a crucial measure to ensure safety nets are readily available for these targeted population.
Literatur
1.
Zurück zum Zitat (2011) Global status report on non-communicable diseases 2010. World Health Organization: Geneva (2011) Global status report on non-communicable diseases 2010. World Health Organization: Geneva
2.
Zurück zum Zitat de Souza JA, Wong Y-N (2013) Financial distress in cancer patients. J Med Pers 11:73–77CrossRef de Souza JA, Wong Y-N (2013) Financial distress in cancer patients. J Med Pers 11:73–77CrossRef
3.
Zurück zum Zitat van Doorslaer E et al. (2005) Paying out-of-pocket for health care in Asia: catastrophic and poverty impact. EQUITAP Project : Working Paper No. 2 van Doorslaer E et al. (2005) Paying out-of-pocket for health care in Asia: catastrophic and poverty impact. EQUITAP Project : Working Paper No. 2
4.
Zurück zum Zitat Kim J, Garman ET, Sorhaindo B (2003) Relationships among credit counseling clients’ financial well-being, financial behaviors, financial stressor events, and health. J Assoc Financ Counsel Plan Educ 14(2):75–87 Kim J, Garman ET, Sorhaindo B (2003) Relationships among credit counseling clients’ financial well-being, financial behaviors, financial stressor events, and health. J Assoc Financ Counsel Plan Educ 14(2):75–87
5.
Zurück zum Zitat Aldana SG (1998) Validity and reliability of a financial strain survey. J Financ Counsel Plan 9(2):11–19 Aldana SG (1998) Validity and reliability of a financial strain survey. J Financ Counsel Plan 9(2):11–19
6.
Zurück zum Zitat Rettig K, Leichtentritt R, Danes S (1999) The effects of resources, decision making, and decision implementing on perceived family well-being in adjusting to an economic stressor. J Fam Econ Issue 20(1):5–34CrossRef Rettig K, Leichtentritt R, Danes S (1999) The effects of resources, decision making, and decision implementing on perceived family well-being in adjusting to an economic stressor. J Fam Econ Issue 20(1):5–34CrossRef
7.
Zurück zum Zitat Joo S, Grable JE (2004) An exploratory framework of the determinants of financial satisfaction. J Fam Econ Issue 25(1):25–50CrossRef Joo S, Grable JE (2004) An exploratory framework of the determinants of financial satisfaction. J Fam Econ Issue 25(1):25–50CrossRef
10.
Zurück zum Zitat Gupta D, Lis CG, Grutsch JF (2007) Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer 15:1051–1056PubMedCrossRef Gupta D, Lis CG, Grutsch JF (2007) Perceived cancer-related financial difficulty: implications for patient satisfaction with quality of life in advanced cancer. Support Care Cancer 15:1051–1056PubMedCrossRef
11.
Zurück zum Zitat Bona K et al (2013) Economic impact of advanced pediatric cancer on families. J Pain Symptom Manag 47(3):594–603CrossRef Bona K et al (2013) Economic impact of advanced pediatric cancer on families. J Pain Symptom Manag 47(3):594–603CrossRef
12.
Zurück zum Zitat Pezzin LE, O’Niel MB, Nattinger AB (2009) The economic consequences of breast cancer adjuvant hormonal treatments. J Gen Intern Med 24(2):446–450PubMedCentralCrossRef Pezzin LE, O’Niel MB, Nattinger AB (2009) The economic consequences of breast cancer adjuvant hormonal treatments. J Gen Intern Med 24(2):446–450PubMedCentralCrossRef
13.
Zurück zum Zitat Markman M, Luce R (2010) Impact of the cost of cancer treatment: an internet-based survey. Am Soc Clin Oncol 6(2):69–73 Markman M, Luce R (2010) Impact of the cost of cancer treatment: an internet-based survey. Am Soc Clin Oncol 6(2):69–73
14.
Zurück zum Zitat Shankaran V et al (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614PubMedCrossRef Shankaran V et al (2012) Risk factors for financial hardship in patients receiving adjuvant chemotherapy for colon cancer: a population-based exploratory analysis. J Clin Oncol 30(14):1608–1614PubMedCrossRef
16.
Zurück zum Zitat Heath JA et al (2006) Childhood cancer: its impact and financial costs for Australian families. Pediatr Hematol Oncol 23(5):439–448PubMedCrossRef Heath JA et al (2006) Childhood cancer: its impact and financial costs for Australian families. Pediatr Hematol Oncol 23(5):439–448PubMedCrossRef
17.
Zurück zum Zitat Kodama Y et al (2012) Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey. BMC Cancer 12:152PubMedCentralPubMedCrossRef Kodama Y et al (2012) Increased financial burden among patients with chronic myelogenous leukaemia receiving imatinib in Japan: a retrospective survey. BMC Cancer 12:152PubMedCentralPubMedCrossRef
18.
Zurück zum Zitat Zaidi AA, Ansari TZ, Khan A (2012) The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital. Int J Equity Health 11:60PubMedCentralPubMedCrossRef Zaidi AA, Ansari TZ, Khan A (2012) The financial burden of cancer: estimates from patients undergoing cancer care in a tertiary care hospital. Int J Equity Health 11:60PubMedCentralPubMedCrossRef
19.
Zurück zum Zitat Longo CJ et al (2006) Financial and family burden associated with cancer treatment in Ontario. Can Support Care Cancer 14:1077–1085CrossRef Longo CJ et al (2006) Financial and family burden associated with cancer treatment in Ontario. Can Support Care Cancer 14:1077–1085CrossRef
20.
Zurück zum Zitat Rogers SN et al (2012) Patients’ perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg 50:410–416PubMedCrossRef Rogers SN et al (2012) Patients’ perception of the financial impact of head and neck cancer and the relationship to health related quality of life. Br J Oral Maxillofac Surg 50:410–416PubMedCrossRef
21.
22.
Zurück zum Zitat J, M.-T.S. (1998) “C” is for costs, and cancer, and conference: highlights of the first European conference on the economics of cancer. J Oncol Pharm Pract. 4(2): 125–128 J, M.-T.S. (1998) “C” is for costs, and cancer, and conference: highlights of the first European conference on the economics of cancer. J Oncol Pharm Pract. 4(2): 125–128
23.
Zurück zum Zitat Brown ML (2002) Estimating health care costs related to cancer treatment from the SEER-Medicare data. Med Care 40:104–117CrossRef Brown ML (2002) Estimating health care costs related to cancer treatment from the SEER-Medicare data. Med Care 40:104–117CrossRef
24.
Zurück zum Zitat Gotsadze G, Zoidze A, Rukhadze N (2009) Household catastrophic health expenditure: evidence from Georgia and its policy implications. BMC Health Serv Res 9:69PubMedCentralPubMedCrossRef Gotsadze G, Zoidze A, Rukhadze N (2009) Household catastrophic health expenditure: evidence from Georgia and its policy implications. BMC Health Serv Res 9:69PubMedCentralPubMedCrossRef
25.
Zurück zum Zitat Somkotra T, Lagrada LP (2009) Which households are at risk of catastrophic health spending: experience in Thailand after universal coverage. Health Aff 28(3):W467–W478CrossRef Somkotra T, Lagrada LP (2009) Which households are at risk of catastrophic health spending: experience in Thailand after universal coverage. Health Aff 28(3):W467–W478CrossRef
26.
Zurück zum Zitat Su TT, Kouyate B, Flessa S (2006) Catastrophic household expenditure for health care in a low-income society: a study from Nouna District, Burkina Faso. Bull World Health Organ 84(1):21–27PubMedCentralPubMedCrossRef Su TT, Kouyate B, Flessa S (2006) Catastrophic household expenditure for health care in a low-income society: a study from Nouna District, Burkina Faso. Bull World Health Organ 84(1):21–27PubMedCentralPubMedCrossRef
27.
Zurück zum Zitat Yardim MS, Cilingiroglu N, Yardim N (2010) Catastrophic health expenditure and impoverishment in Turkey. Health Policy 94(1):26–33PubMedCrossRef Yardim MS, Cilingiroglu N, Yardim N (2010) Catastrophic health expenditure and impoverishment in Turkey. Health Policy 94(1):26–33PubMedCrossRef
28.
Zurück zum Zitat Berki SE (1986) A look at catastrophic medical expenses and the poor. Health Aff 5(4):138–145CrossRef Berki SE (1986) A look at catastrophic medical expenses and the poor. Health Aff 5(4):138–145CrossRef
29.
Zurück zum Zitat Pradhan M, Prescott N (2002) Social risk management options for medical care in Indonesia. Health Econ 11:431–446PubMedCrossRef Pradhan M, Prescott N (2002) Social risk management options for medical care in Indonesia. Health Econ 11:431–446PubMedCrossRef
30.
Zurück zum Zitat Xu K et al (2003) Household catastrophic health expenditure: a multicountry analysis. Lancet 362(9378):111–117PubMedCrossRef Xu K et al (2003) Household catastrophic health expenditure: a multicountry analysis. Lancet 362(9378):111–117PubMedCrossRef
31.
Zurück zum Zitat Huffman MD et al (2011) A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS ONE 6:6CrossRef Huffman MD et al (2011) A cross-sectional study of the microeconomic impact of cardiovascular disease hospitalization in four low- and middle-income countries. PLoS ONE 6:6CrossRef
32.
Zurück zum Zitat Alvarez-Hernández E, Peláez-Ballestas I, Boonen A, Vázquez-Mellado J, Hernández-Garduño A, Rivera FC, Teran-Estrada L, Ventura-Ríos L, Ram-os-Remus C, Skinner-Taylor C, Goycochea-Robles MV, Bernard-Medina AG, Burgos-Vargas R (2012) Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis. Reumatología Clínica 8(4):168–173PubMedCrossRef Alvarez-Hernández E, Peláez-Ballestas I, Boonen A, Vázquez-Mellado J, Hernández-Garduño A, Rivera FC, Teran-Estrada L, Ventura-Ríos L, Ram-os-Remus C, Skinner-Taylor C, Goycochea-Robles MV, Bernard-Medina AG, Burgos-Vargas R (2012) Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis. Reumatología Clínica 8(4):168–173PubMedCrossRef
Metadaten
Titel
The perceived cancer-related financial hardship among patients and their families: a systematic review
verfasst von
Meram Azzani
April Camilla Roslani
Tin Tin Su
Publikationsdatum
01.03.2015
Verlag
Springer Berlin Heidelberg
Erschienen in
Supportive Care in Cancer / Ausgabe 3/2015
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-014-2474-y

Weitere Artikel der Ausgabe 3/2015

Supportive Care in Cancer 3/2015 Zur Ausgabe

Adjuvante Immuntherapie verlängert Leben bei RCC

25.04.2024 Nierenkarzinom Nachrichten

Nun gibt es auch Resultate zum Gesamtüberleben: Eine adjuvante Pembrolizumab-Therapie konnte in einer Phase-3-Studie das Leben von Menschen mit Nierenzellkarzinom deutlich verlängern. Die Sterberate war im Vergleich zu Placebo um 38% geringer.

Alectinib verbessert krankheitsfreies Überleben bei ALK-positivem NSCLC

25.04.2024 NSCLC Nachrichten

Das Risiko für Rezidiv oder Tod von Patienten und Patientinnen mit reseziertem ALK-positivem NSCLC ist unter einer adjuvanten Therapie mit dem Tyrosinkinase-Inhibitor Alectinib signifikant geringer als unter platinbasierter Chemotherapie.

Bei Senioren mit Prostatakarzinom auf Anämie achten!

24.04.2024 DGIM 2024 Nachrichten

Patienten, die zur Behandlung ihres Prostatakarzinoms eine Androgendeprivationstherapie erhalten, entwickeln nicht selten eine Anämie. Wer ältere Patienten internistisch mitbetreut, sollte auf diese Nebenwirkung achten.

ICI-Therapie in der Schwangerschaft wird gut toleriert

Müssen sich Schwangere einer Krebstherapie unterziehen, rufen Immuncheckpointinhibitoren offenbar nicht mehr unerwünschte Wirkungen hervor als andere Mittel gegen Krebs.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.